Is Fallopian Tube Removal Safe? Risks & Recovery
At a Glance
Fallopian tube removal (salpingectomy) is highly safe and effectively lowers the risk of ovarian cancer. Complication rates are very low, and it does not cause early menopause if the ovaries are preserved. However, the procedure results in permanent sterility.
In this answer
3 sections
Yes, fallopian tube removal (salpingectomy) is widely considered to be a highly safe and effective procedure for preventing ovarian cancer. (Note: If you have already been diagnosed with ovarian cancer, fallopian tube removal is likely part of your active surgical treatment plan; this page focuses on the safety of the procedure when used proactively to prevent cancer, which may be relevant for you to understand or for your at-risk family members).
When performed as part of another planned surgery—such as a hysterectomy, a C-section, or tubal ligation—it does not significantly increase operative time, blood loss, or the risk of major complications [1][2][3]. For those having it as a standalone procedure, complication rates remain very low [4]. Most importantly, research shows that removing the tubes substantially lowers the risk of developing ovarian cancer without typically causing early menopause [5][6][7].
A Critical Note on Fertility: Removing both fallopian tubes results in permanent, irreversible sterility. Once the tubes are removed, a natural pregnancy is no longer possible. If you wish to have biological children in the future, you would need to use in vitro fertilization (IVF).
Surgical Risks and Recovery
Every surgery carries some risk, but salpingectomy is considered low-risk [4]. Potential surgical complications are similar to those of any pelvic surgery, including rare risks like infection, bleeding, or injury to nearby structures like the bladder or blood vessels [8].
When the fallopian tubes are removed during another procedure (known as opportunistic salpingectomy), the recovery time and surgical risks are generally the same as they would be for the primary surgery alone [1][9]. If you are having a salpingectomy as a standalone surgery, it is typically performed as a minimally invasive (laparoscopic) outpatient procedure. Most people can go home the same day and expect a full recovery in about 1 to 3 weeks.
To maximize cancer prevention and avoid issues like painful fluid buildup in the remaining tissue, the surgeon must remove the entire tube, especially the fimbriae (the finger-like ends closest to the ovaries) [10][11].
Hormonal Health and Menopause
A common concern is whether removing the fallopian tubes will trigger surgical menopause or disrupt hormonal balance. The medical consensus is that salpingectomy alone does not cause an earlier onset of natural menopause [7][12].
The ovaries produce your hormones, not the fallopian tubes. As long as the ovaries remain in place and their blood supply is carefully preserved during the surgery, short-term data consistently shows no significant negative effects on ovarian reserve (your egg quantity and quality) [6][13]. While a few studies have noted a mild decline in Anti-Müllerian Hormone (AMH, a blood marker used to estimate ovarian reserve) in some individuals [14][15], this slight drop does not mean you will enter menopause early. However, it is something to discuss with a fertility specialist if you plan to pursue IVF in the future, as it may slightly reduce the number of eggs retrieved during IVF [16][17]. The vast majority of research supports that overall hormonal function remains stable [18][19].
How It Lowers Ovarian Cancer Risk
Most high-grade serous ovarian cancers—the most common and aggressive type—actually begin in the fallopian tubes, specifically in the fimbriae, rather than the ovaries themselves [5][20]. By removing the tubes entirely, you remove the primary site where these dangerous cancer cells originate.
For people at an average risk of ovarian cancer, opportunistic salpingectomy during another surgery is a highly effective, cost-saving strategy to reduce cancer risk [21][22].
For people at a high genetic risk (such as those with a BRCA mutation), the gold standard for cancer prevention remains removing both the tubes and the ovaries (risk-reducing salpingo-oophorectomy or RRBSO) [23]. However, because removing the ovaries causes immediate surgical menopause, clinical trials are currently studying an alternative: removing the tubes early and delaying the removal of the ovaries until a later age [24][25]. Until these trials confirm long-term safety, this two-step approach is usually only recommended as part of a research study [25].
Common questions in this guide
Does removing my fallopian tubes cause early menopause?
Can I still get pregnant after a fallopian tube removal?
What is the recovery time for a fallopian tube removal?
Why do doctors remove fallopian tubes to prevent ovarian cancer?
Do I need my ovaries removed if I have a high genetic risk for ovarian cancer?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.What surgical technique will you use to ensure the entire fallopian tube, including the fimbriae, is removed?
- 2.If I am having another surgery (like a C-section or hysterectomy), will removing my tubes add any specific risks to my recovery?
- 3.How will you protect the blood supply to my ovaries during the procedure?
- 4.Given my personal and family history, am I a candidate for keeping my ovaries, or should both my tubes and ovaries be removed?
- 5.If I am doing this as a standalone procedure, what will my specific recovery timeline look like?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
Related questions
References
References (25)
- 1
Operative Outcomes of Opportunistic Bilateral Salpingectomy at the Time of Benign Hysterectomy in Low-Risk Premenopausal Women: A Systematic Review.
Kho RM, Wechter ME
Journal of minimally invasive gynecology 2017; (24(2)):218-229 doi:10.1016/j.jmig.2016.12.004.
PMID: 27988392 - 2
Prophylactic Salpingectomy during Hysterectomy for Benign Disease: A Prospective Study to Evaluate High-Grade Serous Ovarian Carcinoma Precursors.
Tchartchian G, Bojahr B, Heils L, et al.
Journal of clinical medicine 2022; (12(1)) doi:10.3390/jcm12010296.
PMID: 36615096 - 3
Impact of opportunistic salpingectomy on anti-Müllerian hormone in patients undergoing laparoscopic hysterectomy: a multicentre randomised controlled trial.
Song T, Kim MK, Kim ML, et al.
BJOG : an international journal of obstetrics and gynaecology 2017; (124(2)):314-320 doi:10.1111/1471-0528.14182.
PMID: 27342222 - 4
Complications Following Bilateral Salpingectomy by Indication: Population-Based Cohort Study.
Lukey A, do Valle HA, Howard AF, et al.
BJOG : an international journal of obstetrics and gynaecology 2026; (133(5)):1056-1064 doi:10.1111/1471-0528.70143.
PMID: 41502233 - 5
Outcomes From Opportunistic Salpingectomy for Ovarian Cancer Prevention.
Hanley GE, Pearce CL, Talhouk A, et al.
JAMA network open 2022; (5(2)):e2147343 doi:10.1001/jamanetworkopen.2021.47343.
PMID: 35138400 - 6
Ovarian reserve after salpingectomy: a systematic review and meta-analysis.
Mohamed AA, Yosef AH, James C, et al.
Acta obstetricia et gynecologica Scandinavica 2017; (96(7)):795-803 doi:10.1111/aogs.13133.
PMID: 28471535 - 7
Examining indicators of early menopause following opportunistic salpingectomy: a cohort study from British Columbia, Canada.
Hanley GE, Kwon JS, McAlpine JN, et al.
American journal of obstetrics and gynecology 2020; (223(2)):221.e1-221.e11 doi:10.1016/j.ajog.2020.02.005.
PMID: 32067967 - 8
Postpartum Salpingectomy Compared With Standard Tubal Ligation After Vaginal Delivery.
Wagar MK, Godecker A, Landeros MV, Williams M
Obstetrics and gynecology 2021; (137(3)):514-520 doi:10.1097/AOG.0000000000004285.
PMID: 33595245 - 9
The performance and safety of bilateral salpingectomy for ovarian cancer prevention in the United States.
Hanley GE, McAlpine JN, Pearce CL, Miller D
American journal of obstetrics and gynecology 2017; (216(3)):270.e1-270.e9 doi:10.1016/j.ajog.2016.10.035.
PMID: 27810554 - 10
Uncloaking the Fimbria Ovarica: Histologic Recognition of an Elusive Anatomic Structure.
Seidman JD, Stone R, Moragianni VA, et al.
The American journal of surgical pathology 2025; (49(10)):1042-1059 doi:10.1097/PAS.0000000000002414.
PMID: 40338147 - 11
Development of Hydrosalpinx After Prior Vaginal Hysterectomy and Bilateral Salpingectomy.
Lai JM, Masten M, Markese A
Cureus 2024; (16(1)):e52573 doi:10.7759/cureus.52573.
PMID: 38371103 - 12
STop OVarian CAncer (STOPOVCA) young: Protocol for a multicenter follow-up study to determine the long-term effects of opportunistic salpingectomy on age at menopause.
Gelderblom ME, IntHout J, Hermens RPMG, et al.
Maturitas 2022; (159()):62-68 doi:10.1016/j.maturitas.2022.01.006.
PMID: 35337614 - 13
A Study to Evaluate the Effect of Opportunistic Salpingectomy on Ovarian Reserve and Function.
Gupta V, Agarwal S, Chaudhari P, et al.
Journal of obstetrics and gynaecology of India 2023; (73(1)):62-68 doi:10.1007/s13224-022-01709-9.
PMID: 36879936 - 14
Effect of opportunistic salpingectomy at hysterectomy on anti-Müllerian hormone: A substudy of a randomized trial.
Darelius A, Idahl A, Sundfeldt K, Strandell A
Acta obstetricia et gynecologica Scandinavica 2026; (105(8)):1480-1489 doi:10.1111/aogs.70247.
PMID: 42157582 - 15
The effect of coenzyme Q10 pretreatment on ovarian reserve in women undergoing hysterectomy with bilateral salpingectomy: a randomised, double-blind, placebo-controlled trial.
Micaraseth K, Tantanavipas S, Hongsakorn W, Singwongsa A
The British journal of nutrition 2025; (133(2)):213-220 doi:10.1017/S0007114524003131.
PMID: 39648702 - 16
Prior salpingectomy impairs the retrieved oocyte number in in vitro fertilization cycles of women under 35 years old without optimal ovarian reserve.
Ho CY, Chang YY, Lin YH, Chen MJ
PloS one 2022; (17(5)):e0268021 doi:10.1371/journal.pone.0268021.
PMID: 35507603 - 17
Salpingectomy may decrease antral follicle count but not live birth rate for IVF-ET patients aged 35-39 years: a retrospective study.
Chen T, Zhao F, Wang Q, et al.
Journal of ovarian research 2020; (13(1)):80 doi:10.1186/s13048-020-00678-9.
PMID: 32684158 - 18
Comparison of the Effects of Different Routes of Hysterectomy With Salpingectomy Procedures on the Ovarian Reserve, Ovarian Doppler, and Sexual Function Parameters.
Aytekin AM, Ulusoy HE, Efe MA, et al.
The journal of obstetrics and gynaecology research 2026; (52(6)):e70351 doi:10.1111/jog.70351.
PMID: 42225434 - 19
Opportunistic Salpingectomy for Prevention of Tubo-Ovarian Carcinoma: The European Society of Gynaecological Oncology Consensus Statements.
Piek JM, Schauwaert J, Ellis LB, et al.
JAMA 2026; (335(10)):894-902 doi:10.1001/jama.2025.24510.
PMID: 41627806 - 20
Opportunistic Salpingectomy at the Time of Urogynecologic Surgery: Why, in Whom, and How?
Catanzarite T, Eskander RN
Female pelvic medicine & reconstructive surgery 2020; (26(6)):401-406 doi:10.1097/SPV.0000000000000741.
PMID: 31135579 - 21
The potential for opportunistic salpingectomy to reduce ovarian cancer in women undergoing non-gynecologic surgery.
Cook IC, Podwika SE, Hallowell PT, et al.
Gynecologic oncology reports 2025; (58()):101685 doi:10.1016/j.gore.2025.101685.
PMID: 40084062 - 22
Opportunistic salpingectomy during gynecologic and non-gynecologic abdominopelvic procedures for ovarian cancer primary prevention: a cost-effectiveness analysis.
Adjei NN, Yeh PG, Haas A, et al.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2026; (36(6)):102884 doi:10.1016/j.ijgc.2025.102884.
PMID: 41605705 - 23
Patient reported outcomes after risk-reducing surgery in patients at increased risk of ovarian cancer.
Philp L, Alimena S, Ferris W, et al.
Gynecologic oncology 2022; (164(2)):421-427 doi:10.1016/j.ygyno.2021.12.017.
PMID: 34953629 - 24
Screening and prevention of ovarian cancer.
Sideris M, Menon U, Manchanda R
The Medical journal of Australia 2024; (220(5)):264-274 doi:10.5694/mja2.52227.
PMID: 38353066 - 25
Salpingectomy for the Risk Reduction of Ovarian Cancer: Is It Time for a Salpingectomy-alone Approach?
Boerner T, Long Roche K
Journal of minimally invasive gynecology 2021; (28(3)):403-408 doi:10.1016/j.jmig.2020.09.020.
PMID: 33038519
This page is for informational purposes only and does not replace professional medical advice. Always consult your gynecologist or oncologist regarding your specific surgical risks, fertility goals, and cancer prevention options.
Get notified when new evidence is published on Ovarian Cancer.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.